Natalizumab reduces visual loss in patients with relapsing multiple sclerosis

L. J. Balcer, S. L. Galetta, P. A. Calabresi, C. Confavreux, G. Giovannoni, E. Havrdova, M. Hutchinson, L. Kappos, F. D. Lublin, D. H. Miller, P. W. O'Connor, J. T. Phillips, C. H. Polman, E. W. Radue, R. A. Rudick, W. H. Stuart, A. Wajgt, B. Weinstock-Guttman, D. R. Wynn, F. LynnM. A. Panzara

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Fingerprint

Dive into the research topics of 'Natalizumab reduces visual loss in patients with relapsing multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences